These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 35578896)
1. Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter. Huang Y; Wei L; Huang Y; Wen S; Liu T; Duan X; Wang Y; Zhang H; Fan B; Hu B Jpn J Clin Oncol; 2022 Aug; 52(8):930-943. PubMed ID: 35578896 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Alradhi M; Wen S; Safi M; Al-Danakh A; Wang H; Shopit A; Sun M; Fan B; Li X Cancer Med; 2023 Feb; 12(4):3931-3951. PubMed ID: 36779496 [TBL] [Abstract][Full Text] [Related]
3. Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvis. Fan B; Huang Y; Zhang H; Chen T; Tao S; Wang X; Wen S; Wang H; Lin Z; Liu T; Zhang H; He T; Li X Mol Oncol; 2022 Oct; 16(20):3666-3688. PubMed ID: 36052737 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
5. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Larsen AC Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168 [TBL] [Abstract][Full Text] [Related]
6. A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. Zhang H; Lu X; Huang G; Hua M; Zhang W; Wang T; Huang L; Wang Z; Chen Q; Li J; Yang Q; Yang G BMC Med Genomics; 2022 Jan; 15(1):1. PubMed ID: 34980126 [TBL] [Abstract][Full Text] [Related]
9. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence. Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584 [TBL] [Abstract][Full Text] [Related]
10. Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study. Aron M; Chandrashekar DS; Canete-Portillo S; Brimo F; Williamson SR; Osunkoya AO; Raspollini MR; Kunju LP; Varambally S; Mackinnon AC; Harada S; Netto GJ Mod Pathol; 2023 Dec; 36(12):100333. PubMed ID: 37717923 [TBL] [Abstract][Full Text] [Related]
11. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771 [TBL] [Abstract][Full Text] [Related]
13. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy. Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis. Rizzo A; Mollica V; Santoni M; Massari F Clin Genitourin Cancer; 2022 Oct; 20(5):482-487. PubMed ID: 35858936 [TBL] [Abstract][Full Text] [Related]
15. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder. Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083 [TBL] [Abstract][Full Text] [Related]
16. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis. Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761 [TBL] [Abstract][Full Text] [Related]